Health Catalyst (HCAT) Q4 Earnings and Revenues Beat Estimates
- Health Catalyst (HCAT) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to loss of $0.05 per share a year ago.
- 02/22/2024
|
Health Catalyst (HCAT) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
- Beyond analysts' top -and-bottom-line estimates for Health Catalyst (HCAT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
- 02/19/2024
|
Health Catalyst to Announce Fourth Quarter and Full Year 2023 Operating Results and Host Conference Call on Thursday, February 22, 2024
- SALT LAKE CITY, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its fourth quarter and full year 2023 operating results on Thursday, February 22, 2024, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.
- 02/08/2024
|
Wall Street Analysts Believe Health Catalyst (HCAT) Could Rally 28.97%: Here's is How to Trade
- The consensus price target hints at a 29% upside potential for Health Catalyst (HCAT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- 02/01/2024
|
Health Catalyst to Participate in Upcoming Investor Conference
- SALT LAKE CITY, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Bryan Hunt, Chief Financial Officer, and Adam Brown, Senior Vice President of FP&A and Investor Relations, will participate in the 42nd Annual J.P. Morgan Healthcare Conference, being held in San Francisco. In conjunction, there will be a presentation on Wednesday, January 10, 2024 at 1:30pm PT. The replay of the presentation will be available online at https://ir.healthcatalyst.com.
- 12/14/2023
|
Health Catalyst to Participate in Upcoming Investor Conferences
- SALT LAKE CITY, Nov. 24, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Bryan Hunt, Chief Financial Officer, and Adam Brown, Senior Vice President of FP&A and Investor Relations, will participate in the following upcoming investor conferences:
- 11/24/2023
|
Health Catalyst to Participate in Upcoming Investor Conference
- SALT LAKE CITY, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Bryan Hunt, Chief Financial Officer, and Jack Knight, Director of FP&A and Investor Relations, will participate in the Stephens Annual Investment Conference, being held in Nashville. In conjunction, there will be a fireside chat presentation on Wednesday, November 15, 2023 at 9:00am CT. The replay of the presentation will be available online at https://ir.healthcatalyst.com.
- 11/10/2023
|
Compared to Estimates, Health Catalyst (HCAT) Q3 Earnings: A Look at Key Metrics
- The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 11/02/2023
|
Health Catalyst to Announce Third Quarter 2023 Operating Results and Host Conference Call on Wednesday, November 8, 2023
- SALT LAKE CITY, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its third quarter 2023 operating results on Wednesday, November 8, 2023, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.
- 10/25/2023
|
All You Need to Know About Health Catalyst (HCAT) Rating Upgrade to Strong Buy
- Health Catalyst (HCAT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- 10/17/2023
|
Health Catalyst Sees Growth In Tech-Enabled Managed Services
- Health Catalyst, Inc. provides a healthcare data platform for healthcare service providers. The company has shown promising growth in its tech-enabled managed services offering. However, Health Catalyst still has substantial operating losses and has not made significant progress towards operating breakeven.
- 09/15/2023
|
Health Catalyst, Inc. (HCAT) Q2 2023 Earnings Call Transcript
- Health Catalyst, Inc. (NASDAQ:HCAT ) Q2 2023 Earnings Conference Call August 8, 2023 5:00 PM ET Company Participants Adam Brown - SVP Finance & IR Dan Burton - CEO Bryan Hunt - CFO Conference Call Participants Samir Patel - Evercore ISI Vishal Patel - Piper Sandler Daniel Grosslight - Citi David Larsen - BTIG Jack Wallace - Guggenheim Securities Scott Schoenhaus - Keybanc Capital Richard Close - Canaccord Genuity Sarah James - Cantor Fitzgerald Operator Welcome to the Health Catalyst Second Quarter 2023 Earnings Conference Call. [Operator Instructions] I would now like to turn the call over to Adam Brown, Senior Vice President of FP&A and Investor Relations.
- 08/08/2023
|
Health Catalyst (HCAT) Reports Q2 Earnings: What Key Metrics Have to Say
- The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 08/08/2023
|
Health Catalyst to Participate in Upcoming Investor Conference
- SALT LAKE CITY, July 24, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Bryan Hunt, Chief Financial Officer, and Adam Brown, Senior Vice President of Investor Relations and FP&A, will participate in the Canaccord Genuity 43rd Annual Growth Conference, being held in Boston, including a presentation on Thursday, August 10, 2023 at 11:30am EST. The replay of the presentation will be available online at https://ir.healthcatalyst.com.
- 07/24/2023
|
Health Catalyst to Announce Second Quarter 2023 Operating Results and Host Conference Call on Tuesday, August 8, 2023
- SALT LAKE CITY, July 24, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its second quarter 2023 operating results on Tuesday, August 8, 2023, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.
- 07/24/2023
|
Health Catalyst, Inc. (HCAT) Q1 2023 Earnings Call Transcript
- Health Catalyst, Inc. (NASDAQ:HCAT ) Q1 2023 Earnings Conference Call May 9, 2023 5:00 PM ET Company Participants Adam Brown - Senior Vice President, Finance and Investor Relations Dan Burton - Chief Executive Officer Bryan Hunt - Chief Financial Officer Conference Call Participants Anne Samuel - JPMorgan Jared Haase - William Blair Jessica Tassan - Piper Sandler Elizabeth Anderson - Evercore ISI Anna Kruszenski - SVB Securities Richard Close - Canaccord Genuity Daniel Grosslight - Citi John Ransom - Raymond James Thomas Kelliher - RBC Capital Markets David Larsen - BTIG Jack Wallace - Guggenheim Securities Scott Schoenhaus - Keybanc Capital Operator Welcome to the Health Catalyst First Quarter 2023 Earnings Conference Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for your questions following the presentation.
- 05/10/2023
|
Compared to Estimates, Health Catalyst (HCAT) Q1 Earnings: A Look at Key Metrics
- While the top- and bottom-line numbers for Health Catalyst (HCAT) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 05/09/2023
|
Health Catalyst to Announce First Quarter 2023 Operating Results and Host Conference Call on Tuesday, May 9, 2023
- SALT LAKE CITY, April 25, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its first quarter 2023 operating results on Tuesday, May 9, 2023, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.
- 04/25/2023
|
Does Health Catalyst (HCAT) Have the Potential to Rally 30.43% as Wall Street Analysts Expect?
- The consensus price target hints at a 30.4% upside potential for Health Catalyst (HCAT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- 04/10/2023
|
3 Medical Info Systems Stocks Countering Industry-wide Headwinds
- Zacks Medical Info Systems industry stocks like Inspire Medical Systems (INSP), Olink Holding (OLK) and Health Catalyst (HCAT) are expected to gain even as COVID-19 severity fades.
- 04/04/2023
|
Health Catalyst: Riding A Steady Trend
- Health Catalyst, Inc. has some strong market trends pushing it forward, and with a strong market presence I think the future seems very bright. What propels Health Catalyst's top-line growth is its unique product offering, an impressive record in mergers and acquisitions, and its potential to expand its customer base.
- 03/15/2023
|
Health Catalyst to Participate in Upcoming Investor Conference
- SALT LAKE CITY, March 07, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Bryan Hunt, Chief Financial Officer, and Adam Brown, Senior Vice President of Investor Relations and FP&A, will participate in the 44th Annual Raymond James Institutional Investors Conference, being held in Orlando, including a presentation on Wednesday, March 8, 2023 at 8:05am EST. The replay of the presentation will be available online at https://ir.healthcatalyst.com.
- 03/07/2023
|
Health Catalyst, Inc. (HCAT) Q4 2022 Earnings Call Transcript
- Health Catalyst, Inc. (NASDAQ:HCAT ) Q4 2022 Earnings Conference Call February 28, 2023 5:00 PM ET Company Participants Adam Brown – Senior Vice President-Finance and Investor Relations Dan Burton – Chief Executive Officer Bryan Hunt – Chief Financial Officer Conference Call Participants Stephanie Davis – SVB Securities Anne Samuel – JPMorgan Jared Haase – William Blair Jessica Tassan – Piper Sandler Daniel Grosslight – Citi Elizabeth Anderson – Evercore ISI Richard Close – Canaccord Genuity Thomas Kelliher – RBC Capital Markets David Larsen – BTIG Jack Wallace – Guggenheim Securities Operator Welcome to the Health Catalyst Fourth Quarter and Full Year 2022 Earnings Conference Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for your questions following the presentation.
- 03/01/2023
|
Health Catalyst (HCAT) Reports Q4 Loss, Tops Revenue Estimates
- Health Catalyst (HCAT) delivered earnings and revenue surprises of 50% and 1.16%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 02/28/2023
|
Health Catalyst to Announce Fourth Quarter and Full Year 2022 Operating Results and Host Conference Call on Tuesday, February 28, 2023
- SALT LAKE CITY, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its fourth quarter and full year 2022 operating results on Tuesday, February 28, 2023, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.
- 02/14/2023
|
HCA Healthcare: Expect Performance To Meet Long-Term Target Over Time
- There are several underlying growth drivers further driving the adoption for HCAT solutions. HCAT differentiated product offering, strong M&A track record, and ability to further penetrate existing base of users are what drive top line growth.
- 01/31/2023
|
3 Medical Info Systems Stocks Braving Industry-wide Headwinds
- Zacks Medical Info Systems industry stocks like 10x Genomics (TXG), NextGen Healthcare (NXGN) and Health Catalyst (HCAT) are expected to gain as COVID-19 severity fades.
- 01/17/2023
|
Health Catalyst: Tailwinds As Hospitals Use Tech To Offset Higher Costs
- Health Catalyst, Inc., after a 74% downside, spells opportunity, especially when ratings are all favorable. However, analysts at Evercore think differently and have downgraded Health Catalyst stock.
- 01/05/2023
|
Health Catalyst to Participate in Upcoming Investor Conference
- SALT LAKE CITY, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Bryan Hunt, Chief Financial Officer, and Adam Brown, Senior Vice President of Investor Relations and FP&A, will participate in the 41st Annual J.P. Morgan Healthcare Conference, being held in San Francisco, including a presentation on Tuesday, January 10, 2023 at 3:45pm PT. The replay of the presentation will be available online at https://ir.healthcatalyst.com.
- 12/20/2022
|
Why Shares of Health Catalyst Popped 23.34% on Wednesday
- The company continued its upward trend in revenue growth.
- 11/09/2022
|
Health Catalyst, Inc. (HCAT) Q3 2022 Earnings Call Transcript
- Health Catalyst, Inc. (NASDAQ:HCAT ) Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ET Company Participants Adam Brown - Senior Vice President-Finance and Investor Relations Daniel Burton - Chief Executive Officer Bryan Hunt - Chief Financial Officer Conference Call Participants Anne Samuel - JPMorgan Ryan Daniels - William Blair Jessica Tassan - Piper Sandler Elizabeth Anderson - Evercore ISI Richard Close - Canaccord Genuity Daniel Grosslight - Citi David Larsen - BTIG Cindy Motz - Goldman Sachs Jack Wallace - Guggenheim Securities Operator Welcome to the Health Catalyst Third Quarter 2022 Earnings Conference Call. At this time, all participants have been placed in a listen-only mode and the floor will be opened for your questions following the presentation.
- 11/08/2022
|
Health Catalyst (HCAT) Reports Q3 Loss, Tops Revenue Estimates
- Health Catalyst (HCAT) delivered earnings and revenue surprises of 35% and 2.25%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- 11/08/2022
|
Health Catalyst to Announce Third Quarter 2022 Operating Results and Host Conference Call on Tuesday, November 8, 2022
- SALT LAKE CITY, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its third quarter 2022 operating results on Tuesday, November 8, 2022, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.
- 10/26/2022
|
Health Catalyst: Looking For A Turnaround For This 'Bio Boom' Candidate
- Health Catalyst has been on my "Bio Boom" watch list for a couple of years, but the valuation has stopped me from starting a position. The market-wide sell-off has brought the share price down to an acceptable valuation to allow me to finally find a spot for HCAT in my Compounding Healthcare “Bio Boom” Portfolio.
- 10/14/2022
|
Health Catalyst to Participate in Upcoming Investor Conference
- SALT LAKE CITY, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Bryan Hunt, Chief Financial Officer, and Adam Brown, Senior Vice President of Investor Relations and FP&A, will participate in the Canaccord Genuity 42nd Annual Growth Conference, being held in Boston on Thursday, August 11, 2022, including a fireside chat presentation at 12:00pm ET. The replay of the presentation will be available online at https://ir.healthcatalyst.com.
- 08/10/2022
|
Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q2 2022 Results - Earnings Call Transcript
- Health Catalyst, Inc. (NASDAQ:HCAT ) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Adam Brown – Senior Vice President-Finance and Investor Relations Dan Burton – Chief Executive Officer Bryan Hunt – Chief Financial Officer Conference Call Participants Anne Samuel – J.P. Morgan Jared Haase – William Blair Elizabeth Anderson – Evercore Stephanie Davis – SVB Securities John Ransom – Raymond James Jessica Tassan – Piper Sandler Richard Close – Canaccord Genuity Daniel Grosslight – Citi Rohan Chandrasekhar – Guggenheim Partners Operator Good day, ladies and gentlemen, and thank you for standing by.
- 08/07/2022
|
Health Catalyst (HCAT) Reports Q2 Loss, Tops Revenue Estimates
- Health Catalyst (HCAT) delivered earnings and revenue surprises of 72.73% and 1.23%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- 08/04/2022
|
7 Small-Cap Growth Stocks Trading at a Huge Discount Right Now
- When equities are under pressure, it is particularly important for investors to find stocks that are trading at a discount to their intrinsic value. This can be particularly difficult if you're interested in finding small-cap growth stocks trading at a discount.
- 08/01/2022
|
Health Catalyst to Announce Second Quarter 2022 Operating Results and Host Conference Call on Thursday, August 4, 2022
- SALT LAKE CITY, July 21, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its second quarter 2022 operating results on Thursday, August 4, 2022, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.
- 07/21/2022
|
Health Catalyst to Participate in Upcoming Investor Conferences
- SALT LAKE CITY, June 01, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Bryan Hunt, Chief Financial Officer, and Adam Brown, Senior Vice President of Investor Relations and FP&A, will participate in the following upcoming investor conferences:
- 06/01/2022
|
Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q1 2022 Results - Earnings Call Transcript
- Health Catalyst, Inc. (NASDAQ:HCAT ) Q1 2022 Earnings Conference Call May 10, 2022 5:00 PM ET Company Participants Adam Brown - IR Dan Burton - CEO Bryan Hunt - CFO Conference Call Participants Anne Samuel - JPMorgan Ryan Daniels - William Blair Jessica Tassan - Piper Sandler Cindy Motz - Goldman Sachs Elizabeth Anderson - Evercore Stephanie Davis - SVB Securities Richard Close - Canaccord Genuity John Ransom - Raymond James Daniel Grosslight - Citi David Larsen - BTIG Dev Weerasuriya - Berenberg Operator Good day, and thank you for standing by. Welcome to the Health Catalyst First Quarter 2022 Earnings Conference Call.
- 05/11/2022
|
Health Catalyst (HCAT) Reports Q1 Loss, Tops Revenue Estimates
- Health Catalyst (HCAT) delivered earnings and revenue surprises of 25% and 3.35%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 05/10/2022
|
Health Catalyst to Announce First Quarter 2022 Operating Results and Host Conference Call on Tuesday, May 10, 2022
- SALT LAKE CITY, April 26, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its first quarter 2022 operating results on Tuesday, May 10, 2022, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.
- 04/26/2022
|
Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q4 2021 Results - Earnings Call Transcript
- Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q4 2021 Results - Earnings Call Transcript
- 03/02/2022
|
Health Catalyst (HCAT) Reports Q4 Loss, Tops Revenue Estimates
- Health Catalyst (HCAT) delivered earnings and revenue surprises of 9.52% and 2.60%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
- 03/01/2022
|
Health Catalyst to Participate in Upcoming Investor Conference
- SALT LAKE CITY, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, CEO, Bryan Hunt, CFO, and Adam Brown, SVP of Investor Relations and FP&A, will participate in the 40th Annual J.P. Morgan Healthcare Conference including a presentation on Tuesday, January 11, 2022 at 3:45 p.m. ET. An audio-only replay of the presentation will be available at https://ir.healthcatalyst.com.
- 01/03/2022
|
Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q3 2021 Results - Earnings Call Transcript
- Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q3 2021 Results - Earnings Call Transcript
- 11/09/2021
|
Health Catalyst to Announce Third Quarter 2021 Operating Results and Host Conference Call on Tuesday, November 9, 2021
- SALT LAKE CITY, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its 2021 third quarter operating results on Tuesday, November 9, 2021, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.
- 10/27/2021
|
Bull Of The Day: Heath Catalyst (HCAT)
- This stock had been reporting losses but posted a break-even quarter in the more recent print and that could start a new trend.
- 10/15/2021
|
Health Catalyst to Participate in Upcoming Investor Conference
- SALT LAKE CITY, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Bryan Hunt, CFO, and Adam Brown, SVP of Investor Relations and FP&A, will participate in Cantor Global Healthcare Conference including a fireside chat presentation on Thursday, September 30, 2021 at 1:20 p.m. ET. A webcast link will be available at https://ir.healthcatalyst.com/investor-relations.
- 09/22/2021
|
Health Catalyst, Oklahoma Heart Hospital Team Up to Accelerate Cost-Management Transformation and Improved Patient Outcomes
- SALT LAKE CITY, Aug. 12, 2021 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced an expansive, multi-year partnership with Oklahoma Heart Hospital (OHH), one of the largest cardiovascular networks in the United States. Initially, Health Catalyst and OHH will work to accelerate the organization's efforts to improve revenue cycle analytics and performance, drive transparency on the cost of care, and empower clinicians with the right data to inform their patient care delivery processes.
- 08/12/2021
|
Health Catalyst Announces Pricing of Public Offering of Common Stock
- SALT LAKE CITY, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst”) (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the pricing of an underwritten public offering of 4,245,283 shares of its common stock at a public offering price of $53.00 per share. The gross proceeds to Health Catalyst from the offering are expected to be approximately $225.0 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Health Catalyst. In addition, Health Catalyst has granted the underwriters a 30-day option to purchase up to an additional 636,792 shares of common stock at the public offering price, less underwriting discounts and commissions. All of the shares to be sold in the offering are being offered by Health Catalyst. The offering is expected to close on or about August 13, 2021, subject to satisfaction of customary closing conditions.
- 08/10/2021
|
Health Catalyst Announces Proposed Public Offering of Common Stock
- SALT LAKE CITY, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst”) (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the commencement of an underwritten public offering of $225.0 million of shares of its common stock. All of the shares in the offering are being sold by Health Catalyst. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. In addition, Health Catalyst intends to grant the underwriters a 30-day option to purchase up to $33.75 million of shares of its common stock in the public offering at the public offering price.
- 08/09/2021
|
Catalyst, Inc. (HCAT) CEO Dan Burton on Q2 2021 Results - Earnings Call Transcript
- Catalyst, Inc. (HCAT) CEO Dan Burton on Q2 2021 Results - Earnings Call Transcript
- 08/08/2021
|
Twistle by Health Catalyst Showcases Innovative Ways to Eliminate Disparities in Care at HIMSS21
- ALBUQUERQUE, N.M. and SALT LAKE CITY, Aug. 6, 2021 /PRNewswire/ -- Twistle by Health Catalyst, Inc. (Nasdaq: HCAT) ("Twistle"), a secure communication platform that engages patients in their care, will host a variety of activities at the HIMSS21 Global Conference, including product demonstrations, a Pinksocks giveaway, and a Theater Presentation with Tom Burton, Director of Operations, Orthopedic and Neurosciences at Providence's Southern California Region.
- 08/06/2021
|
Health Catalyst to Participate in Upcoming Investor Conference
- SALT LAKE CITY, July 30, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Bryan Hunt, CFO, and Adam Brown, SVP of Investor Relations and FP&A, will participate in the 41st Annual Canaccord Genuity Growth Stock Conference including a fireside chat presentation on Wednesday, August 11, 2021 at 2:00 p.m. ET.
- 07/30/2021
|
New Strong Sell Stocks for July 21st
- CNO, CLOV, DMAC, HCAT and IMAX have been added to the Zacks Rank #5 (Strong Sell) List on July 21, 2021.
- 07/21/2021
|
Health Catalyst Launches Value Optimizer - A New Approach to Managing Risk and Achieving Profitability in Population Health
- SALT LAKE CITY, July 21, 2021 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst,") (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the launch of Value Optimizer™, a new population health solution that quickly identifies highly valuable opportunities for value-based care (VBC) performance improvement. VBC payment models have become increasingly common as healthcare organizations seek a better approach to managing risk and achieving profitability in population health.
- 07/21/2021
|
HEP Announces Five Realizations and New Investment
- NEW YORK, July 19, 2021 /PRNewswire/ -- Health Enterprise Partners ("HEP"), a healthcare private equity firm, is pleased to announce five realizations of existing portfolio companies, and a new investment in Kno2, the tenth platform investment out of HEP III. Following a tradition of backing founder-financed businesses, HEP's investment came as part of the first source of institutional capital raised by each of these six companies.
- 07/19/2021
|
Health Catalyst Announces Agreement to Acquire Twistle
- SALT LAKE CITY, June 24, 2021 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that it has entered into a definitive agreement to acquire Twistle, Inc. ("Twistle"), an Albuquerque, New Mexico-based healthcare patient engagement SaaS technology company that automates patient-centered, HIPAA-compliant communication between care teams and patients to transform the patient experience, drive better care outcomes, and reduce healthcare costs. We anticipate that Twistle's leading clinical workflow and patient engagement platform, paired with the Health Catalyst population health offering, will enable a comprehensive go-to-market solution to address the population health needs of healthcare organizations, as well as Life Science organizations, around the globe.
- 06/24/2021
|
Health Catalyst to Participate in Upcoming Investor Conference
- SALT LAKE CITY, May 28, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, CEO, and Adam Brown, SVP of Investor Relations and FP&A, will participate in the 41st Annual William Blair Growth Stock Conference including a fireside chat on Wednesday, June 2, 2021 at 5:40 p.m. ET. A webcast link will be available at https://ir.healthcatalyst.com/investor-relations.
- 05/28/2021
|
This Powerful Partnership Could Be Game Over for an Entire Industry
- It might also be the first domino to fall as big tech takes over healthcare.
- 05/27/2021
|
Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q1 2021 Results - Earnings Call Transcript
- Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q1 2021 Results - Earnings Call Transcript
- 05/09/2021
|
Health Catalyst (HCAT) Reports Q1 Loss, Tops Revenue Estimates
- Health Catalyst (HCAT) delivered earnings and revenue surprises of 53.85% and 3.25%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
- 05/06/2021
|
7 Tech Stocks Becoming Healthcare Stocks
- Covid-19 has meant many tech stocks now put more resources in healthcare. These technology shares deserve to be on your radar.
- 04/01/2021
|
Health Catalyst's Dan Burton Named a Utah Business CEO of the Year
- SALT LAKE CITY, March 31, 2021 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst") (NASDAQ: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton was named a "CEO of the Year 2021" by Utah Business. This award recognizes chief executive officers who have led their organizations with strength, courage, and endurance, and made a positive impact in Utah.
- 03/31/2021
|
Health Catalyst Launches New Healthcare.AI™ to Deliver Augmented Intelligence at Scale to Healthcare Industry
- SALT LAKE CITY, March 10, 2021 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst,") (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the launch of the new Healthcare.AI™. Created to address healthcare business opportunities and challenges across revenue, cost, and quality, the Healthcare.AI suite of augmented intelligence (AI) products and services will significantly expand the effective use and use cases of AI in healthcare.
- 03/10/2021
|
HCAT Stock Price: $54 Target (Up From $50) By Piper Sandler
- The shares of Health Catalyst Inc (NASDAQ: HCAT) have received a price target increase from $50 to $54 by Piper Sandler. These are the details.
- 03/06/2021
|
Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q4 2020 Results - Earnings Call Transcript
- Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q4 2020 Results - Earnings Call Transcript
- 02/28/2021
|
Health Catalyst to Participate in Upcoming Investor Conferences
- SOUTH JORDAN, Utah, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Bryan Hunt, CFO and Adam Brown, SVP of Investor Relations and FP&A, will participate in the following upcoming investor conferences:
- 02/26/2021
|
Recap: Health Catalyst Q4 Earnings
- Shares of Health Catalyst (NASDAQ:HCAT) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 23.81% year over year to ($0.16), which beat the estimate of ($0.19).
- 02/25/2021
|
Health Catalyst Reports Fourth Quarter and Year End 2020 Results
- SOUTH JORDAN, Utah, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2020.
- 02/25/2021
|
Health Catalyst to Announce Fourth Quarter and Full Year 2020 Operating Results and Host Conference Call on Thursday, February 25, 2021
- SALT LAKE CITY, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its fourth quarter and full year 2020 operating results on Thursday, February 25, 2021, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.
- 02/09/2021
|
Health Catalyst Leader Appointed to Primary Care and Chronic Illness Standing Committee
- SALT LAKE CITY, Jan. 11, 2021 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Stephen Grossbart, Ph.D., Senior Vice President of Professional...
- 01/11/2021
|
Health Catalyst to Participate in Upcoming Investor Conference
- SALT LAKE CITY, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, CEO, Bryan Hunt, CFO and Adam Brown, SVP of Investor Relations and FP&A, will participate in the 39th Annual J.P. Morgan Healthcare Conference to be held virtually January 11-14, 2021. This will include a presentation by Mr. Burton and Mr. Hunt on Monday, January 11, 2021 at 5:20 p.m. EST. An audio replay of the presentation will be available at https://ir.healthcatalyst.com/investor-relations.
- 12/22/2020
|
Health Catalyst: Growth At The Intersection Of Health And Data
- US healthcare costs have ballooned in recent years, yet at least 25% of that spending is due to general inefficiency. Health Catalyst provides a way for healthcare organizations to manage their data and derive analytical insights all within a single platform.
- 12/15/2020
|
Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q3 2020 Results - Earnings Call Transcript
- Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q3 2020 Results - Earnings Call Transcript
- 11/10/2020
|
Health Catalyst (HCAT) Reports Q3 Loss, Tops Revenue Estimates
- Health Catalyst (HCAT) delivered earnings and revenue surprises of 22.22% and 5.69%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
- 11/10/2020
|
Health Catalyst: Q3 Earnings Insights
- Shares of Health Catalyst (NASDAQ:HCAT) rose 2.39% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 22.22% over the past year to ($0.21), which beat the estimate of ($0.27).
- 11/10/2020
|
Health Catalyst Reports Third Quarter 2020 Results
- SALT LAKE CITY, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended September 30, 2020.
- 11/10/2020
|
Health Catalyst Promotes Patrick Nelli to the Role of President
- Announces Promotion of Bryan Hunt as CFO and Additional Leadership Responsibilities to Support Continued Growth and Expansion Announces Promotion of Bryan Hunt as CFO and Additional Leadership Responsibilities to Support Continued Growth and Expansion
- 11/10/2020
|
Health Catalyst to Participate in Upcoming Investor Conference
- SALT LAKE CITY, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Patrick Nelli, Chief Financial Officer, and Adam Brown, Senior Vice President, Investor Relations, will participate in the 29th Annual Credit Suisse Virtual Healthcare Conference on Thursday, November 12, 2020, which will include a fireside chat presentation at 2:45 p.m. ET. A live audio webcast and replay of this presentation will be available at https://ir.healthcatalyst.com/investor-relations.
- 11/02/2020
|
Tracking Chase Coleman's Tiger Global Portfolio - Q2 2020 Update
- Chase Coleman’s 13F portfolio value increased from $16.61B to $25.79B this quarter. Tiger Global added CrowdStrike Holdings and increased Salesforce.com during the quarter.
- 09/10/2020
|
Health Catalyst - Looks Cheap But Where Is The Catalyst?
- Health Catalyst has just seen its first year anniversary as a publicly traded company. The company sees continued growth, although at lower rates, yet has real work to be done on the bottom line.
- 08/30/2020
|
Health Catalyst and Northwell Health Partner to Transform Patient Care with Cloud-Based Data and Analytics Enterprise Solution
- Northwell Health today joined Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, in announcing a long-term strategic partnership to transform the quality of patient care by using data and analytics to better anticipate and respond to the evolving needs of patients, providers and payers in today's rapidly evolving healthcare ecosystem.
- 08/12/2020
|
Health Catalyst Inc (HCAT) Q2 2020 Earnings Call Transcript
- Ladies and gentlemen, thank you for standing by and welcome to the Health Catalyst, Inc. Q2 2020 earnings conference call. Good afternoon and welcome to Health Catalyst's earnings conference call for the second quarter of 2020 which ended on June 30, 2020. My name is Adam Brown, I'm the senior vice president of investor relations for Health Catalyst, and with me on the call is Dan Burton, our chief executive officer; and Patrick Nelli, our chief financial officer.
- 08/12/2020
|
Health Catalyst: Q2 Earnings Insights
- Shares of Health Catalyst (NASDAQ:HCAT) fell 8.31% in after-market trading after the company reported Q2 results.Quarterly Results Earnings per share rose 28.57% over the past year to ($0.15), which beat the estimate of ($0.22).Revenue of $43,259,000 rose by 17.54% year over year, which beat the estimate of $42,140,000.Looking Ahead Earnings guidance hasn't been issued by the company for now.The upcoming fiscal year's revenue expected to be between $177,200,000 and $181,200,000.Conference Call Details Date: Aug 11, 2020View more earnings on HCATTime: 05:00 PMET Webcast URL: https://edge.media-server.com/mmc/p/mnfgfc9jTechnicals Company's 52-week high was at $49.85Company's 52-week low was at $17.48Price action over last quarter: Up 23.50%Company Profile Health Catalyst Inc is engaged in providing data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, which is the key revenue driver, includes data platform, analytics applications and support services. This generates revenues primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; and Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.See more from Benzinga * Earnings Scheduled For August 11, 2020 * Benzinga's Top Upgrades, Downgrades For June 18, 2020(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- 08/11/2020
|
Health Catalyst (HCAT) Reports Q2 Loss, Tops Revenue Estimates
- Health Catalyst (HCAT) delivered earnings and revenue surprises of 37.50% and 3.24%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
- 08/11/2020
|
Health Catalyst Announces Agreement to Acquire Vitalware, a Revenue Workflow Optimization and Analytics SaaS Technology Solution
- SALT LAKE CITY, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that it has entered into a definitive agreement to acquire Vitalware, LLC, a Yakima, Washington-based provider of revenue workflow optimization and analytics SaaS technology solutions to healthcare organizations. Vitalware’s flagship offering is a Best in KLAS chargemaster management solution that delivers results for the complex regulatory and compliance functions needed by all healthcare provider systems. Additionally, Vitalware brings to bear newer product suites in Revenue Integrity, to help health systems capture lost revenue, and Price Transparency, to support compliance with expanding pricing transparency regulation. Importantly, Vitalware offers Health Catalyst a strategic anchor technology in the revenue space, expanding its CFO offering and value proposition. Vitalware’s solutions support all major EMRs and act as a key integration point for health systems with multiple EMRs.Health Catalyst CEO Dan Burton said, “We are excited to welcome the Vitalware team to support our shared mission to be the catalyst for massive, measurable improvements. In addition to adding a best in KLAS technology solution from Vitalware, this acquisition is another powerful example of Health Catalyst’s ability to integrate and scale software on top of our DOS™ platform. Ultimately, DOS, our cloud-based data platform, will further enhance the analytics insights made available by Vitalware’s technology by integrating charge and revenue data with claims, cost, and quality data.”“Vitalware, since inception, has been about delivering solutions that provide critical insights and better financial outcomes to health systems,” said Vitalware CEO and Co-founder, Kerry Martin. “We have a great team committed to our clients and their success, and adding the expertise and solutions from the Health Catalyst team will allow Vitalware to deliver even more innovative solutions. Our number one priority continues to be to create positive outcomes for our clients, and we’re confident the combination of our resources with Health Catalyst will only accelerate that effort.”Health Catalyst expects to fund the transaction using a mix of stock and cash. The parties expect the transaction, which is subject to customary closing conditions, to close in the third or fourth quarter of 2020. Further details regarding the acquisition will be reported on a Form 8-K filing that will be filed with the Securities and Exchange Commission today.About Health Catalyst Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations, and is committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.About Vitalware Vitalware is the leading mid-cycle revenue SaaS solutions provider, specializing in Health-IT applications aimed at making the business of healthcare easier through its intuitive cloud-based technologies and regulatory content expertise. With nearly 1,000 hospitals on its client roster, Vitalware’s product portfolio is the healthcare industry’s best solution for providing visibility and continuity in chargemaster management, pricing transparency, charge capture, and regulatory code references. Beyond providing tools, and healthcare regulatory and compliance resources, Vitalware offers professional services designed to support organizations’ need of coding guidance, process improvement, education, and financial impact solutions. Vitalware is recognized as a 2020 Best in KLAS software for its VitalCDM® platform. Visit our website, www.vitalware.com.Cautionary Note Regarding Forward-Looking Statements This press release contains forward-looking statements relating to expectations, plans, and prospects including expectations relating to our ability to close, and the timing of the closing of, this transaction and the benefits that will be derived from this transaction. These forward-looking statements are based upon the current expectations and beliefs of Health Catalyst’s management as of the date of this release, and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements including, without limitation, the risk of adverse and unpredictable macro-economic conditions and risks related to closing this transaction and integration of the companies. All forward-looking statements in this press release are based on information available to the Company as of the date hereof, and Health Catalyst disclaims any obligation to update these forward-looking statements.Health Catalyst Investor Relations Contact: Adam Brown Senior Vice President, Investor Relations +1 (855)-309-6800 ir@healthcatalyst.comHealth Catalyst Media Contact: Kristen Berry Senior Vice President, Public Relations +1 (617) 234-4123 +1 (774) 573-0455 (m) kberry@we-worldwide.com
- 08/11/2020
|
Health Catalyst Reports Second Quarter 2020 Results
- SALT LAKE CITY, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2020. “First, let me express our ongoing gratitude to all the heroic national health systems and their front-line workers. We are both grateful and honored that our health system customers have continued to trust us so meaningfully to support them in this time of great need,” said Dan Burton, CEO of Health Catalyst. “From a financial perspective, I am very pleased with our performance in the second quarter across all areas of our business, including outperforming the mid-point of our guidance for both total revenue and Adjusted EBITDA. In addition to this financial and operational execution, I was particularly pleased to see that our team member overall satisfaction score, as measured by Gallup, ranked in the 99th percentile once again. This past period's score, the second highest in the company's history, was particularly encouraging as we adapted to a remote-only culture.” Mr. Burton continued: “We are hosting our seventh annual Healthcare Analytics Summit in September. While the format will be virtual this year, we continue to believe this conference represents a meaningful opportunity for Health Catalyst to continue to provide thought leadership within the healthcare data and analytics ecosystem, while carefully listening to our customers and prospects as we further cultivate and deepen those relationships. The theme of this year's conference will be healthcare analytics in the ‘new normal’, and we are fortunate to feature many of the leading voices in the country as our keynote speakers.”Financial Highlights for the Three Months Ended June 30, 2020 Key Financial Metrics Three Months Ended Year over June 30, Year 2020 2019 Change GAAP Financial Data:(in thousands, except percentages) Technology revenue$25,487 $20,085 27% Professional services revenue$17,772 $16,719 6% Total revenue$43,259 $36,804 18% Loss from operations$(15,640) $(9,363) (67)% Net loss$(27,183) $(10,694) (154)% Other Non-GAAP Financial Data:(1) Adjusted Technology Gross Profit$17,493 $13,072 34% Adjusted Technology Gross Margin69% 65% Adjusted Professional Services Gross Profit$3,730 $6,193 (40)% Adjusted Professional Services Gross Margin21% 37% Total Adjusted Gross Profit$21,223 $19,265 10% Total Adjusted Gross Margin49% 52% Adjusted EBITDA$(4,188) $(5,749) 27% ________________________ (1) These measures are not calculated in accordance with generally accepted accounting principles in the United States (GAAP). See the accompanying "Non-GAAP Financial Measures" section below for more information about these financial measures, including the limitations of such measures, and for a reconciliation of each measure to the most directly comparable measure calculated in accordance with GAAP.Financial Outlook Health Catalyst provides forward-looking guidance on total revenue, a GAAP measure, and Adjusted EBITDA, a non-GAAP measure.For the third quarter of 2020, we expect: * Total revenue between $43.0 million and $46.0 million, and * Adjusted EBITDA between $(8.9) million and $(6.9) millionFor the full year of 2020, we expect: * Total revenue between $177.2 million and $181.2 million, and * Adjusted EBITDA between $(25.5) million and $(22.5) millionWe have not reconciled guidance for Adjusted EBITDA to net loss, the most directly comparable GAAP measure, and have not provided forward-looking guidance for net loss, because there are items that may impact net loss, including stock-based compensation, that are not within our control or cannot be reasonably predicted.Quarterly Conference Call Details The company will host a conference call to review the results today, Tuesday, August 11, 2020 at 5:00 p.m. E.T. The conference call can be accessed by dialing 1-877-295-1104 for U.S. participants, or 1-470-495-9486 for international participants, and referencing participant code 2285626. A live audio webcast will be available online at https://ir.healthcatalyst.com/. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.About Health Catalyst Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.Available InformationHealth Catalyst intends to use its Investor Relations website as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.Forward-Looking Statements This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements include statements regarding our future growth and our financial outlook for Q3 2020. Forward-looking statements are subject to risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking statements. Actual results may differ materially from the results predicted, and reported results should not be considered as an indication of future performance.Important risks and uncertainties that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: (i) changes in laws and regulations applicable to our business model; (ii) changes in market or industry conditions, regulatory environment and receptivity to our technology and services; (iii) results of litigation or a security incident; (iv) the loss of one or more key customers or partners; (v) the impact of COVID-19 on our business and results of operation; and (vi) changes to our abilities to recruit and retain qualified team members. For a detailed discussion of the risk factors that could affect our actual results, please refer to the risk factors identified in our SEC reports, including, but not limited to the Annual Report on Form 10-K for the year ended December 31, 2019 filed with the SEC on February 28, 2020 and the Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2020 expected to be filed with the SEC on or about August 12, 2020. All information provided in this release and in the attachments is as of the date hereof, and we undertake no duty to update or revise this information unless required by law.Condensed Consolidated Balance Sheets (in thousands, except share and per share data, unaudited) As of As of June 30, December 31, 2020 2019 Assets Current assets: Cash and cash equivalents$104,185 $18,032 Short-term investments248,932 210,245 Accounts receivable, net34,426 27,570 Deferred costs455 937 Prepaid expenses and other assets8,955 7,455 Total current assets396,953 264,239 Property and equipment, net3,835 4,295 Intangible assets, net29,435 25,535 Operating lease right-of-use assets15,417 3,787 Other assets2,337 810 Goodwill18,419 3,694 Total assets$466,396 $302,360 Liabilities and stockholders’ equity Current liabilities: Accounts payable$2,398 $3,622 Accrued liabilities7,487 8,944 Acquisition-related consideration payable3,164 2,192 Deferred revenue35,173 30,653 Operating lease liabilities1,963 2,806 Total current liabilities50,185 48,217 Long-term debt, net of current portion163,480 48,200 Acquisition-related consideration payable, net of current portion— 1,860 Deferred revenue, net of current portion2,176 1,459 Operating lease liabilities, net of current portion13,913 1,654 Contingent consideration liability1,457 — Other liabilities1,223 326 Total liabilities232,434 101,716 Commitments and contingencies Stockholders’ equity: Common stock, $0.
- 08/11/2020
|
Health Catalyst to Participate in Upcoming Investor Conferences
- SALT LAKE CITY, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Patrick Nelli, Chief Financial Officer, and Adam Brown, Senior Vice President, Investor Relations, will participate in the following upcoming investor conferences. * Verity Research HCIT / Services Conference being held virtually on Wednesday, August 12, 2020, which will include a fireside chat presentation at 4:00 p.m. EST. * Canaccord Genuity 40th Annual Growth Conference being held virtually on Thursday, August 13, 2020, which will include a fireside chat presentation at 10:00 a.m. EST.About Health CatalystHealth Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.Health Catalyst Investor Relations Contact:Adam Brown Senior Vice President, Investor Relations +1 (855)-309-6800 ir@healthcatalyst.comHealth Catalyst Media Contact:Kristen Berry Vice President, Public Relations +1 (617) 234-4123 +1 (774) 573-0455 (m) kberry@we-worldwide.com
- 08/10/2020
|
Why Earnings Season Could Be Great for Health Catalyst (HCAT)?
- Health Catalyst (HCAT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 08/10/2020
|
Health Catalyst (HCAT) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
- Health Catalyst (HCAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 08/04/2020
|
Health Catalyst to Announce Second Quarter 2020 Operating Results and Host Conference Call on Tuesday, August 11, 2020
- SALT LAKE CITY, July 29, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its 2020 second quarter operating results on Tuesday, August 11, 2020, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-877-295-1104 for U.S. participants, or 1-470-495-9486 for international participants, and referencing participant code 2285626. A live audio webcast that will be available online at https://ir.healthcatalyst.com/. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.About Health Catalyst Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.Health Catalyst Investor Relations Contact:Adam Brown Senior Vice President, Investor Relations +1 (855)-309-6800 ir@healthcatalyst.comHealth Catalyst Media Contact:Kristen Berry Vice President, Public Relations +1 (617) 234-4123 +1 (774) 573-0455 (m) kberry@we-worldwide.com
- 07/29/2020
|
Health Catalyst Offers Planning Resources for COVID-19 Recovery
- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the release of its Financial Impact Recovery applications. Designed to support hospital and healthcare systems' COVID-19 financial recovery as they navigate the dynamics of patient care during a pandemic, these applications provide meaningful ways to prioritize and monitor progress on elective surgery backlog, outpatient visit backlog and revenue cycle. These solutions, which have rapid implementation timelines, are built on the Health Catalyst Data Operating System (DOS™).
- 07/28/2020
|
How Much Of Health Catalyst, Inc. (NASDAQ:HCAT) Do Insiders Own?
- Every investor in Health Catalyst, Inc. (NASDAQ:HCAT) should be aware of the most powerful shareholder groups...
- 07/23/2020
|
Health Catalyst's Shares March Higher, Can It Continue?
- As of late, it has definitely been a great time to be an investor in Health Catalyst.
- 07/23/2020
|
Health Catalyst (NASDAQ:HCAT) Rating Increased to Buy at Zacks Investment Research
- Zacks Investment Research upgraded shares of Health Catalyst (NASDAQ:HCAT) from a sell rating to a buy rating in a research note published on Wednesday morning, Zacks.com reports. The firm currently has $36.00 price objective on the stock. According to Zacks, “Health Catalyst Inc. is a provider of data and analytics technology and services to healthcare […]
- 07/19/2020
|
Health Catalyst Announces Agreement to Acquire healthfinch, a Healthcare IT Company that has Helped Define the Clinical Workflow Optimization Space with its Award-Winning Software
- SALT LAKE CITY, July 09, 2020 -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare.
- 07/09/2020
|
Health Catalyst Launches New Care Management Solution
- Today, Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, announced the launch of its Care Management Suite, a patient-centric data- and analytics-driven approach to care management. These tools and processes deliver visibility across the continuum of care for high-risk and at-risk populations, enable the integration of multiple disparate data sources, facilitate more streamlined and patient-centric workflows, improve the quality of patient care, and reduce overall costs.
- 07/01/2020
|
Analysts Offer Insights on Healthcare Companies: Catasys (NASDAQ: CATS), Akero Therapeutics (NASDAQ: AKRO) and Zynerba Pharmaceuticals (NASDAQ: ZYNE) - Markets
- There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Catasys (CATS
- 07/01/2020
|
Hedge Funds Have Never Been This Bullish On Health Catalyst, Inc (HCAT)
- We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March 31st, near the height of the coronavirus market crash. In this article, we look at what those funds think […]
- 06/28/2020
|
3 Big Data Health Stocks to Watch in 2020 | The Motley Fool
- Big data is becoming a big factor in the healthcare industry.
- 06/24/2020
|
Analysts Offer Insights on Healthcare Companies: InflaRx (NASDAQ: IFRX), 1Life Healthcare (NASDAQ: ONEM) and Inari Medical (NASDAQ: NARI) - Markets
- Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on InflaRx (IFRX –
- 06/22/2020
|
M&T Bank Corp Purchases New Stake in Health Catalyst (NASDAQ:HCAT)
- M&T Bank Corp acquired a new position in shares of Health Catalyst (NASDAQ:HCAT) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 10,875 shares of the company’s stock, valued at approximately $284,000. Several other institutional investors and hedge funds also recently added to or reduced their […]
- 06/20/2020
|
Health Catalyst Participating in the COVID-19 Evidence Accelerator, a Public-Private Partnership to Advance Understanding of COVID-19
- Today, Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, announced its participation in the COVID-19 Evidence Accelerator, an expansive public-private partnership that combines the efforts of academic, government, and private sector organizations by applying real-world data to advance the understanding of COVID-19. The COVID-19 Evidence Accelerator was launched by the Reagan-Udall Foundation for the FDA, in collaboration with Friends of Cancer Research (Friends).
- 06/18/2020
|
Health Catalyst Launches Application to Overcome Performance Data Fragmentation
- Today, Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, announced that it will be offering a comprehensive quality measures solution that combines its Data Operating System (DOS™) with a scalable measures application designed to improve provider quality measurement.
- 06/10/2020
|
Zacks: Analysts Expect Health Catalyst (NASDAQ:HCAT) Will Announce Quarterly Sales of $41.78 Million
- Wall Street brokerages expect Health Catalyst (NASDAQ:HCAT) to announce sales of $41.78 million for the current quarter, Zacks reports. Six analysts have provided estimates for Health Catalyst’s earnings, with the lowest sales estimate coming in at $40.99 million and the highest estimate coming in at $42.66 million. Health Catalyst reported sales of $36.80 million in […]
- 06/10/2020
|
Health Catalyst to Participate in Upcoming Investor Conferences
- SALT LAKE CITY, June 03, 2020 -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare.
- 06/03/2020
|
Global Healthcare Analytics Market by Component, Deployment Mode, Type, Application, End-user and Region - Forecast to 2025 - ResearchAndMarkets.com
|
Health Catalyst Inc (HCAT) Q1 2020 Earnings Call Transcript
- Ladies and gentlemen, thank you for standing by, and welcome to the Health Catalyst, Inc. first-quarter 2020 earnings conference call. Good afternoon, and welcome to Health Catalyst's earnings conference call for the first quarter of 2020, which ended on March 31, 2020. My name is Adam Brown.
- 05/13/2020
|
Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q1 2020 Results - Earnings Call Transcript
- Health Catalyst, Inc. (NASDAQ:HCAT) Q1 2020 Earnings Conference Call May 12, 2020, 08:30 AM ET Company Participants Adam Brown - SVP, IR Dan Burton - CEO Patric
- 05/13/2020
|
Health Catalyst Reports First Quarter 2020 Results
- SALT LAKE CITY, May 12, 2020 -- Health Catalyst, Inc. (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today.
- 05/12/2020
|
Mark Templeton Appointed to Health Catalyst Board of Directors
- Mr. Templeton was appointed to fill an upcoming vacancy after Promod Haque’s current term expires at Health Catalyst’s 2020 annual meeting of its stockholders on June 12, 2020. Mr. Templeton will serve until Health Catalyst’s 2022 annual meeting of its stockholders.
- 05/12/2020
|
The Zacks Analyst Blog Highlights: LOGI, GO, GFL, HCAT and VIE
- The Zacks Analyst Blog Highlights: LOGI, GO, GFL, HCAT and VIE
- 05/12/2020
|
Should You Buy Health Catalyst (HCAT) Ahead of Earnings?
- Health Catalyst (HCAT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 05/11/2020
|
Were Hedge Funds Right About Health Catalyst, Inc (HCAT)?
- We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P; 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
- 05/06/2020
|
10 Small-Cap Stocks to Buy for HUGE Gains in the Next 10 Years
- These small-cap stocks could rise by 1,000% or more in the 2020s, making them some of the best stocks to buy for the next 10 years.
- 05/04/2020
|
What's in the Cards for CVS Health (CVS) in Q1 Earnings?
- We expect CVS Health (CVS) to have gained from Aetna's addition of new Individual and Group Medicare Advantage members in Q1.
- 05/01/2020
|
What's in the Cards for CVS Health (CVS) in Q1 Earnings?
- We expect CVS Health (CVS) to have gained from Aetna's addition of new Individual and Group Medicare Advantage members in Q1.
- 05/01/2020
|
What will the Oracle say?
- News is free at Seeking Alpha.This post is a Notable Call. Notable Calls are a Premium feature.To access this and other Notable Calls, try a free trial to Seeking Alpha Premium.
- 05/01/2020
|
Gives His Opinion On GM, American Airlines And More
- On CNBC's "Mad Money Lightning Round," Jim Cramer said Prudential Financial's (NYSE: PRU) payout is too high and that concerns him. In his career, when he tried to reach for yield, he was rarely right.The aerospace is on hold but Spirit AeroSystems Holdings, Inc. (NYSE: SPR) can bounce
- 04/29/2020
|
Health Catalyst to Announce First Quarter 2020 Operating Results and Host Conference Call on Tuesday, May 12, 2020
- SALT LAKE CITY, April 28, 2020 -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare.
- 04/28/2020
|
SunTrust Robinson Sticks to Its Buy Rating for Health Catalyst (HCAT)
- SunTrust Robinson analyst Sandy Draper maintained a Buy rating on Health Catalyst (HCAT) today and set a price target of $30.00. The company's shares
- 04/22/2020
|
SunTrust Robinson Sticks to Its Buy Rating for Health Catalyst (HCAT)
- SunTrust Robinson analyst
Sandy Draper
maintained a
Buy
rating on Health Catalyst (
HCAT
–
Research Report
) today and set a price target of
$30.00
. The company’s shares closed last Wednesday at $25.10.
According to
TipRanks.com
, Draper is a 5-star
- 04/22/2020
|
Health Catalyst (HCAT) Receives a Buy from Cantor Fitzgerald
- In a report issued on April 20, Steven Halper from Cantor Fitzgerald reiterated a Buy rating on Health Catalyst (HCAT), with a price target of $44.00. The
- 04/22/2020
|
Health Catalyst (HCAT) Receives a Buy from Cantor Fitzgerald
- In a report issued on April 20, Steven Halper from Cantor Fitzgerald reiterated a Buy rating on Health Catalyst (HCAT
- 04/22/2020
|
Health Catalyst (HCAT) Receives a Buy from RBC Capital
- In a report issued on April 20, Sean Dodge from RBC Capital maintained a Buy rating on Health Catalyst (HCAT), with a price target of $30.00. The
- 04/22/2020
|
Health Catalyst (HCAT) Receives a Buy from RBC Capital
- In a report issued on April 20, Sean Dodge from RBC Capital maintained a Buy rating on Health Catalyst (HCAT
- 04/22/2020
|
UBS softens view on Eli Lilly in premarket analyst action
- Allscripts Healthcare Solutions (NASDAQ:MDRX) initiated with an Outperform rating and an $8 (21% upside) price target at RBC.Aprea Therapeutics (NASDAQ:APRE) initiated with an Outperform rating and a
- 04/21/2020
|
Health Catalyst National Data Repository Helps Clients Battle COVID-19
- Healthcare providers and public health authorities across the country are struggling to answer complex questions related to the COVID-19 pandemic. Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT) is analyzing the data in its Touchstone™ platform of 80 million de-identified patient records to produce real-world COVID-19 insights related to surveillance, testing, capacity planning, and treatment response—and making the results of that analysis available to customers, health systems, public health authorities, state and local government, and biopharma working on vaccine and therapeutics development.
- 04/20/2020
|
Health Catalyst and Carle Health Partner to Improve Patient Care with Data and Analytics Solutions
- Carle Health today joined Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, in announcing a five year, multi-million dollar strategic partnership to improve the quality of patient care, lower costs and meet the changing needs of patients, providers and payors in today's rapidly evolving healthcare marketplace.
- 04/14/2020
|
Leerink rolls out lineup of bullish calls in premarket analyst action
- Allogene Therapeutics (NASDAQ:ALLO) initiated with Buy rating and $29 (28% upside) price target at SunTrust.Allscripts Healthcare Solutions (NASDAQ:MDRX) initiated with Market Perform rating and $8 (1
- 04/13/2020
|
Health Catalyst (HCAT) Gets a Buy Rating from Canaccord Genuity
- In a report issued on April 9, Richard Close from Canaccord Genuity maintained a Buy rating on Health Catalyst (HCAT), with a price target of $40.00. The
- 04/13/2020
|
Health Catalyst (HCAT) Gets a Buy Rating from Canaccord Genuity
- In a report issued on April 9, Richard Close from Canaccord Genuity maintained a Buy rating on Health Catalyst (HCAT
- 04/13/2020
|
IFR US ECM Calendar
- NEW YORK, April 9 (IFR) -
- 04/09/2020
|
Health Catalyst, Inc. Prices Upsized Offering of $200 Million 2.50% Convertible Senior Notes Due 2025
- Health Catalyst, Inc. (HCAT) (the “Company” or “Health Catalyst”) announced today the pricing of $200.0 million aggregate principal amount of 2.50% convertible senior notes due 2025 (the “notes”) in a private offering (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering was upsized from the previously announced offering of $175.0 million aggregate principal amount of notes. In connection with the offering, the Company granted the initial purchasers an option to purchase up to an additional $30.0 million aggregate principal amount of notes.
- 04/09/2020
|
IFR US ECM Calendar
- NEW YORK, April 8 (IFR) -
- 04/08/2020
|
Fly Intel: Pre-market Movers EHTH;NVAX;PINS;UPS;FDX;RPM;SGH;GNMK;TLGT;AMC;HCAT;GLUU;IQ;W
- Fly Intel: Pre-market Movers EHTH NVAX PINS UPS FDX RPM SGH GNMK TLGT AMC HCAT GLUU IQ W
- 04/08/2020
|
Health Catalyst, Inc. Announces Proposed Offering of $175 Million Convertible Senior Notes
- Health Catalyst, Inc. (HCAT) (the “Company” or “Health Catalyst”) announced today that it intends to offer, subject to market conditions and other factors, $175.0 million aggregate principal amount of convertible senior notes due 2025 (the “notes”) in a private offering (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). In connection with the offering, the Company expects to grant the initial purchasers an option to purchase up to an additional $26.25 million aggregate principal amount of notes. The Company intends to use a portion of the net proceeds from the offering of notes to pay the cost of the capped call transactions described below and approximately $57.0 million of the net proceeds to repay in full and terminate its term loan facility.
- 04/08/2020
|
Health Catalyst (NASDAQ:HCAT) Shares Purchased by Janus Henderson Group PLC
- Janus Henderson Group PLC increased its position in shares of Health Catalyst (NASDAQ:HCAT) by 4.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 143,673 shares of the company’s stock after acquiring an additional 5,640 shares during the period. Janus […]
- 04/06/2020
|
Morgan Stanley likes Bristol-Myers Squibb in premarket analyst action
- Exact Sciences (NASDAQ:EXAS) initiated with an Outperform rating and a $70 (25% upside) price target at Evercore ISI.Health Catalyst (NASDAQ:HCAT) initiated with a Buy rating and a $40 (47% upside) pr
- 04/02/2020
|
Analysts Offer Insights on Technology Companies: Health Catalyst (HCAT) and Okta (OKTA)
- Analysts have been eager to weigh in on the Technology sector with new ratings on Health Catalyst (HCAT) and Okta (OKTA). Health Catalyst (HCAT) Canaccord
- 04/02/2020
|
Analysts Offer Insights on Technology Companies: Health Catalyst (NASDAQ: HCAT) and Okta (NASDAQ: OKTA)
- Analysts have been eager to weigh in on the Technology sector with new ratings on Health Catalyst (
HCAT
–
Research Report
) and Okta (
OKTA
–
Research Report
).
Health Catalyst (HCAT)
Canaccord Genuity analyst
Richard Close
initiated coverage with a
- 04/02/2020
|
Health Catalyst Launches Four Additional COVID-19 Solutions and a Modular Bundle
- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced meaningful developments in its initial COVID-19 solutions and is launching the following: a COVID-19 Registry, Dashboard, and
- 03/31/2020
|
SunTrust Robinson Reaffirms Their Buy Rating on Health Catalyst (HCAT)
- In a report released today, Sandy Draper from SunTrust Robinson maintained a Buy rating on Health Catalyst (HCAT), with a price target of $35.00. The
- 03/26/2020
|
SunTrust Robinson Reaffirms Their Buy Rating on Health Catalyst (HCAT)
- In a report released today,
Sandy Draper
from SunTrust Robinson maintained a
Buy
rating on Health Catalyst (
HCAT
–
Research Report
), with a price target of
$35.00
. The company’s shares closed last Monday at $25.69.
According to
TipRanks.com
, Drap
- 03/26/2020
|
3 Healthcare Stocks to Buy for AI and Big Data
- Healthcare stocks are in the spotlight as the coronavirus brings to light the importance of collecting data and using it to predict outcomes.
- 03/26/2020
|
Health Catalyst Expands COVID-19 Response Support and Provides Infrastructure to Enable Readiness for Future Demands
- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that multiple client sites are already using its new COVID-19 Solutions announced last week, well ahead of the anticipated March 31 launch. Additionally, a growing number of its health system clients are using the company's agile, adaptable, open Data Operating System's (DOS) ingestion, warehousing, analytics and services capabilities to meet evolving COVID-19-driven demands. More capabilities and solution refinements are surfacing and becoming available, including public health surveillance reporting for seven states and longer-term infrastructure planning for the anticipated next wave of COVID-19 and other novel viruses, with this future readiness enabled by DOS.
- 03/24/2020
|
Health Catalyst Plans to Support Health System Clients' COVID-19 Response with Three Initial Solutions Focused on Patient Tracking, Public Health Surveillance and Staff Augmentation Support
- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that, after dozens of conversations with health system clients, the company will initially be offering three COVID-19 Solutions to its domestic clients, with the first of these solutions becoming available to pilot clients by the end of March. The technology associated with these solutions will be offered to all clients at no incremental cost through the end of 2020. In the days and weeks ahead, Health Catalyst will continue to explore with clients additional potential analytics solutions helpful in addressing the COVID-19 situation.
- 03/17/2020
|
Tracking Chase Coleman's Tiger Global Portfolio - Q4 2019 Update
- Chase Coleman’s 13F portfolio value decreased from $18.88B to $18.12B this quarter. Tiger Global increased Uber Technologies & Elastic NV while decreasing Sales
- 03/08/2020
|
GDS (NASDAQ:GDS) versus Health Catalyst (NASDAQ:HCAT) Head-To-Head Comparison
- GDS (NASDAQ:GDS) and Health Catalyst (NASDAQ:HCAT) are both business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations and profitability. Earnings & Valuation This table compares GDS and Health Catalyst’s top-line revenue, earnings per share and […]
- 03/02/2020
|
Health Catalyst Reports Fourth Quarter and Year End 2019 Results
- SALT LAKE CITY, Feb. 27, 2020 -- Health Catalyst, Inc. (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today.
- 02/27/2020
|
J.P. Morgan: 2 “Strong Buy” Healthcare Stocks With Over 50% Upside
- Digitization of the world we live in has disrupted the healthcare industry, giving rise to the healthcare information technology (IT) segment of the market. The emergence of this space and the technology it offers has transformed the way healthcare providers and organizations care for patients. Not to mention efficiency has improved dramatically. Demand for these digital solutions isn’t expected to slow anytime soon, with Grand View Research predicting that the digital healthcare market will expand at a CAGR of 27%, reaching $509.2 billion by 2025.Bearing this in mind, investing firm J.P. Morgan took a look at several healthcare IT names ahead of their upcoming fourth quarter earnings releases.“Sentiment on the group has been largely favorable, with the group up 12% since Q3 earnings in November vs the remaining Healthcare Technology & Distribution group up 14% and the SPX 8%-plus,” analyst Anne Samuel commented.In the report, the firm highlights two tickers in particular that it believes can not only deliver solid prints, but also reward investors through 2020 and beyond. After using TipRanks’ Stock Screener tool, we found out each boasts a “Strong Buy” consensus rating from the Street, and has a substantial upside potential from the current share price. We’re talking more than 50% here.Health Catalyst Inc. (HCAT)With its cloud-based data platform, Health Catalyst offers data and analytics solutions to healthcare organizations. As the company gears up for its February 27 earnings release, J.P. Morgan has high hopes.The investment banking firm's analyst, Anne Samuel, notes that she will be focused on how many new Data Operating System (DOS) clients were added during the year as well as dollar-based retention. Additionally, Samuel highlights the fact that the company thinks the Medicity conversion opportunity is approaching an inflection point in 2020 given that this past summer, cross-sell conversations kicked off.Based on Samuel’s estimates, the analyst expects net new customers for 2019 to land at 14, which would reflect 28% year-over-year customer growth. In terms of 2020 guidance, she is forecasting 18 net new DOS subscription customers and 7% same-store growth, amounting to 25% DOS subscription revenue growth. However, thanks to Medicity drag, the total revenue gain is expected to come in at 22%. As a result, this brings the 2020 revenue prediction to $186 million, which falls in line with the consensus.While Samuel does point out that HCAT operates in a highly competitive environment and that there could be an expense shift of $200,00 from Q3 into Q4, her bullish thesis remains very much intact. “We see significant white space in an $8 billion TAM, with over 20% revenue growth driven by mid-teens annual customer wins. We estimate the company reaches EBTIDA profitability in the next four years as a maturing customer base drives incremental leverage. The model is predictable with over 90% recurring revenue, 107% net dollar-based retention, and a sticky customer base, never having lost an all-access customer,” the analyst explained.Taking all of this into consideration, Samuel maintained both her Overweight call and $50 price target. Should this target be met, shares could be in for a twelve-month gain of 66%. (To watch Samuel’s track record, click here)Overall, it has been relatively quiet when it comes to other analyst activity. In the last three months, only 3 analysts have issued ratings. However, as they were all Buys, the word on the Street is that HCAT is a Strong Buy. Based on the $48.33 average price target, shares could climb 60% higher in the next twelve months. (See Health Catalyst stock analysis on TipRanks)Livongo Health Inc. (LVGO)Moving on to the firm’s next pick, we come across Livongo Health. For patients battling chronic health conditions, its digital health platform makes it easy to access personalized digital guidance and health coaching through a smart connected device. While the healthcare name has experienced significant volatility, the firm remains optimistic.Ahead of its Q4 earnings release on March 2, Samuel, who also covers this stock, wrote that LVGO already “blessed Street numbers on its Q3 call for $276 million equating to 63% year-over-year growth.” She added, “Looking at the economic value added (EVA) that they reported in Q3, a 40% conversion rate on $208 million year-to-date EVA would equate to a 70% revenue growth run rate on our math.”When the results are announced, Samuel anticipates that the Street will be paying close attention to 2020 guidance and the sustainability of rapid growth, noting that management stated 2020 will be an “investment year”. On top of this, the analyst is hoping for an update on enrollment, pipeline for new growth and any changes in the competitive landscape.In terms of the fourth quarter figures, Samuel is calling for revenue of $49.4 million and an EBITDA loss of $5.5 million, both of which would land within the guided range. For 2020, the analyst expects the company to guide for $281 million in revenue, a 66% increase if achieved, gross profit margins of 72% and a fiscal 2020 EBITDA loss of $25 million.Despite the EBITDA figure being in the red, Samuel believes LVGO will be able to reach operating income profitability in 2021. Additionally, the analyst argued, “The company is minimally penetrated in a vast and growing chronic disease market, as more than half of the U.S. population has one or more chronic conditions and an additional 4,000 Americans are diagnosed with diabetes each day. LVGO’s rapid growth profile is attractive, and unique in Healthcare IT with our model calling for an 85% revenue CAGR over the next 3 years as the company increases its member base.”In line with her optimistic take, Samuel kept an Overweight rating and price target of $43 on the stock. This target conveys her confidence in LVGO’s ability to climb 55% higher in the next twelve months.What does the rest of the Street think about LVGO? As it turns out, other analysts are on the same page. With 100% Street support, the message is clear: the stock is a Strong Buy. Not to mention the $45.67 average price target implies 64% upside potential. (See Livongo stock analysis on TipRanks)
- 02/24/2020
|
Health Catalyst to Participate in Upcoming Investor Conference
- SALT LAKE CITY, Feb. 24, 2020 -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare.
- 02/24/2020
|
Jianpu Technology (NYSE:JT) and Health Catalyst (NYSE:HCAT) Head-To-Head Comparison
- Jianpu Technology (NYSE:JT) and Health Catalyst (NASDAQ:HCAT) are both small-cap business services companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, profitability, analyst recommendations, risk and valuation. Insider & Institutional Ownership 18.0% of Jianpu Technology shares are owned by institutional investors. […]
- 02/22/2020
|
Health Catalyst Announces Agreement to Acquire Able Health, a Leading SaaS Provider of Quality and Regulatory Measurement Tracking and Reporting
- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that it has entered into a definitive agreement to acquire Able Health, Inc. (“Able Health”), a San Francisco-based company that is a leading SaaS provider of quality and regulatory measurement tracking and reporting to healthcare providers and risk-bearing entities. The Able Health SaaS application will strengthen Health Catalyst’s existing Quality and Regulatory Measures capabilities.
- 02/18/2020
|
Financial Review: Weibo (NASDAQ:WB) vs. Health Catalyst (NASDAQ:HCAT)
- Health Catalyst (NASDAQ:HCAT) and Weibo (NASDAQ:WB) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, valuation, dividends, profitability and analyst recommendations. Insider and Institutional Ownership 45.6% of Health Catalyst shares are owned by institutional investors. Comparatively, 26.6% of […]
- 01/23/2020
|
Reviewing Weibo (NASDAQ:WB) and Health Catalyst (NASDAQ:HCAT)
- Weibo (NASDAQ:WB) and Health Catalyst (NASDAQ:HCAT) are both computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Profitability This table compares Weibo and Health Catalyst’s net margins, return on equity and return […]
- 01/20/2020
|
Health Catalyst Could Slump When Lockup Expires
- When the 180-day lockup period for Health Catalyst Inc. expires on January 21, 2020, the company's pre-IPO shareholders and insiders may choose to sell more than 28 million shares in the secondary market.
- 01/16/2020
|
A Stock for Investing in Healthcare Data and Analytics
- Anyone who has worked in information technology for a while knows about the old 'diapers and beer' story which a fellow named Mark Madsen actually got to the bottom of a few years ago. The story goes something like this. Back in the early 90s, a woman named Karen Heath, a senior manager for health analytics with Accenture today, was running SQL queries on datasets at an unspecified Midwest retailer. What she discovered was that the sale of diapers and beer seemed to be highly correlated. The idea was that husbands who were sent to the store to buy diapers also decided that picking up
- 01/02/2020
|
Xconomy: After Drought, Digital Health's Summer of IPOs Brings Validation
- After a nearly three-year period in which not a single digital health company held an initial public stock offering, the dry spell has ended. In recent
- 08/14/2019
|
